Articles On Living Cell Technologies (ASX:LCT)

Title Source Codes Date
In Case You Missed It: Construction materials player beats resources for top spot

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, who made announcements today.   ICYMI Leader...

Stockhead LCT 1 year ago
Living Cell Technologies (ASX:LCT) partners with La Trobe University to advance AI-116 dementia studies

Living Cell Technologies (LCT) is partnering with La Trobe University to conduct multiple pre-clinical studies using AI116 to treat dementia LCT will employ state-of-the-art experimental techniques to aid the process, which will offer in...

themarketherald.com.au LCT 1 year ago
Living Cell Technologies to head pre-clinical studies of AI-116 cannabinoid to treat dementia

Living Cell Technologies (ASX: LCT) has entered into a research agreement with Melbourne’s La Trobe University for a range of pre-clinical studies assessing the effect of cannabinoid-based combination drug AI-116 on patients with dementia....

smallcaps.wpenginepowered.com LCT 1 year ago
ASX Today: Stocks to watch on Friday

Futures are predicting that the ASX will open in the red to end the week, bucking the trend on a week full of positive openings. Meanwhile, Wall Street eagerly awaits US job data. Bitcoin also as experienced a decline overnight, down by...

themarketherald.com.au LCT 1 year ago
Market Highlights: Wall Street’s late selloff, home prices rebound, and 5 ASX small caps to watch today

ASX to open lower today after a late selloff on Wall Street The US Fed’s preferred inflation posted another increase Aussie home prices are staging a recovery – Corelogic report   Australian shares are set to open lower on Friday after a...

Stockhead LCT 1 year ago
LCT making headway on drug candidate pipeline for major disease treatments

Melbourne-headquartered biotechnology company Living Cell Technologies (ASX: LCT) made significant strides in its efforts to create a pharmaceutical company with a diversified product candidate pipeline during a busy June quarter. Boosted b...

smallcaps.wpengine.com LCT 1 year ago
Living Cell Technologies files patent application over combination drug to treat dementia

This content is created by Smallcaps Authors. [Author : Imelda Cotton] Living Cell Technologies (ASX: LCT) has filed a provisional patent application over combination drug candidate AI-116 which contains cannabidiol (CBD) and an off-paten...

SmallCaps LCT 1 year ago
ASX biotech company LCT eyes artificial intelligence-powered drug discovery and development

This content is created by Smallcaps Authors. [Author : Colin Hay] Biotechnology company Living Cell Technologies (ASX: LCT) is preparing to take the next step in a major makeover with a proposal to be put to shareholders to change its na...

SmallCaps LCT 1 year ago
ASX Health Stocks: AVITA’s spray-on skin cells device RECELL pockets US FDA approval

AVITA receives US FDA premarket approval for its RECELL System Living Cell falls after saying it will enact a temporary pause on pig herd facility Oneview Healthcare signs material deal with NYSE-listed Baxter   Regenerative medicine comp...

Stockhead LCT 1 year ago
Living Cell Technologies moves closer to third clinical trial of NTCELL for Parkinson’s disease

This content is created by Smallcaps Authors. [Author : Imelda Cotton] Living Cell Technologies (ASX: LCT) has released a market update on its planned NTCELL clinical trial program for Parkinson’s disease. The company has confirmed that c...

SmallCaps LCT 1 year ago
Living Cell Technologies appoints new chief scientific officer

This content is created by Smallcaps Authors. [Author : Imelda Cotton] Biotechnology company Living Cell Technologies (ASX: LCT) has appointed experienced Australian research scientist Dr James A Mckenna to the role of chief scientific of...

SmallCaps LCT 1 year ago
Living Cell Technologies (ASX:LCT) launches $2.5 million cap raise for Parkinson’s treatment

Living Cell Technologies (LCT) launches a $2.5 million capital raise with Alignment Capital to develop its NTCELL project LCT plans to raise the funds through a $1.2 million share placement, a $750,000 entitlement offer, and an over-allo...

themarketherald.com.au LCT 1 year ago
CLOSING BELL: Shipments increase after China lifts the ban it never put on Aussie coal

The ASX fell today because US data gave Wall Street the willies on Friday A month’s worth of shipping data shows coal shipments to China are on the rise Qantas celebrates last week’s $1bn profit by slashing regional services. Again   Toda...

Stockhead LCT 1 year ago
Closing Bell: It’s trickle down economics… just not the kind you’re thinking of

Wall Street slump leads the ASX into an early morning drop. Thanks, Obama Benchmark strides deeper into the red, graceful as a moose on rollerskates New Age Exploration has a mystical moment at the peak of Mount Profit Well, it’s safe to...

Stockhead LCT 2 years ago
Living Cell Technologies (ASX:LCT) completes stage one of NTCELL manufacture

Living Cell Technologies (LCT) completes stage one of its use of artificial intelligence in the planned manufacturing of NTCELL in Sydney, AustraliaUnder an agreement with OptiCellAI, the two companies will ensure the high quality encapsula...

themarketherald.com.au LCT 2 years ago
This ASX stock is watching you while you sleep… because it could point to Parkinson’s disease

Acting out your dreams could be a sign of a neurological disease, a study finds ASX-listed Pharmaxis to launch a study on iRBD patients who are at risk of Parkinson’s Stockhead reaches out to Pharmaxis CEO, Gary Phillips A rare sleep diso...

Stockhead LCT 2 years ago
Choroid plexus tissue shipped to Sydney as NTCELL research advances

Living Cell Technologies (ASX:LCT) has advanced its Parkinson’s disease research with choroid plexus tissue successfully shipped from New Zealand to Australia as part of the third clinical trial of NTCELL.

BiotechDispatch LCT 2 years ago
LCT, RGS: Biotech players trading in green amidst tumbling healthcare sector

Highlights The healthcare sector comprises stocks from diversified backgrounds, including healthcare services, healthcare equipment, pharmaceuticals, biotechnology, etc. Last month, Living Cell Technologies (ASX:LCT) raised AU$1.285 mi...

Kalkine Media LCT 2 years ago
Living Cell Technologies (ASX:LCT) raises $1.28m for NTCELL

Biotech company Living Cell Technologies (LCT) raises $1.285 million through a private placement to boost its research into Parkinson’s Disease The company issued 257 million new fully-paid ordinary shares to professional and sophisticated...

themarketherald.com.au LCT 2 years ago
Living Cell Technologies (ASX:LCT) pauses trade ahead of capital raise

Living Cell Technologies (LCT) enters a trading halt as the company awaits more details in regards to an upcoming capital raise Trading of shares will be paused until Tuesday, May 31 or until LCT releases more information Earlier this week...

themarketherald.com.au LCT 2 years ago
Living Cell Technologies announces new agreement to use AI in trial

Living Cell Technologies (ASX:LCT) says artificial intelligence will be applied to its research into Parkinson’s disease under a new agreement with OptiCellAI.

BiotechDispatch LCT 2 years ago
Major Breakthrough! Living Cell Technologies (ASX:LCT) to use AI in research for Parkinson’s

Highlights LCT has marked a major leap in its groundbreaking research to combat Parkinson’s disease, which affects millions of people worldwide. The company is set to apply AI in NTCELL research to augment the quality of its third clin...

Kalkine Media LCT 2 years ago
ASX Health Stocks: Oneview extends software deal, LCT to start using AI technology

Oneview extends supply deal to BJC’s hospital beds LCT will start to use artificial intelligence in its research AFT Pharma’s solid FY22 Oneview extends hospital deal with BCJ Health Healthcare software company Oneview Healthcare (ASX:ONE...

Stockhead LCT 2 years ago
Market Highlights and 5 ASX Small Caps to watch on Monday

ASX to open the lower on the first day of the new Labor government Experts say there will be renewed focus on renewables under the new PM Germany’s producer prices soar by a record 33% Local shares are set to drop lower on the first day o...

Stockhead LCT 2 years ago
Check Up: More clinical trials and FDA funding boost. Is this the end of biotech’s woes?

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

Stockhead LCT 2 years ago
NTCELL to be produced in Australia under UTS research agreement

Living Cell Technologies (ASX:LCT) says it has advanced plans for a third clinical trial of NTCELL in Parkinson’s disease.

BiotechDispatch LCT 2 years ago
From IMC to ALA: Healthcare stocks with best YTD returns

Highlights The Australian healthcare sector includes companies engaged in biotechnology and research, food and drug retailing, health care equipment, service providers, and pharmaceuticals. On a YTD basis, the healthcare index is runni...

Kalkine Media LCT 2 years ago
ASX Health Stocks: Clinical trials gather pace for Visioneering Tech, Anteris and other biotechs

The ASX 200 Health Index (XHJ) is falling by 0.3% at the time of writing, compared to the broader index which is down by 0.37%. Visioneering Technologies (ASX:VTI) has enrolled the first patient in its landmark international clinical trial...

Stockhead LCT 2 years ago
Living Cell Technologies (ASX:LCT) sees shortfall from rights issue

Living Cell Technologies (LCT) receives valid applications for new shares and new options under its rights issue which closed on December 21 seeing big shortfall The company initially announced on November 15 it was aiming to raise up to $...

themarketherald.com.au LCT 2 years ago
Closing Bell: ASX hits cruise control ahead of US inflation data

There were few major catalysts on Thursday, as the ASX traded flat in a relatively cruisy session following some solid gains this week. Broadly speaking, the ASX has tracked global stock markets higher after a rocky selloff last week that f...

Stockhead LCT 3 years ago
Reporting Season Round Up: Who shined on the ASX’s Judgement Day?

Today is the deadline for ASX companies to submit their quarterlies. Stockhead has recapped the Top 5 winners in morning trade, as investors responded to the latest earnings report cards. 9Spokes (ASX:9SP) This New Zealand business is a bus...

Stockhead LCT 3 years ago
Closing Bell: ASX fails to maintain gains, despite tech gaining 1.7pc

Just like yesterday the ASX rallied for most of the day but retreated in the afternoon and today closed in the red. The ASX 200 was down 0.08% at 7,375 points. Another difference from yesterday was tech was the best sector gaining 1.7% whil...

Stockhead LCT 3 years ago
10 at 10: These ASX stocks have floated up high this morning

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Stockhead LCT 3 years ago
Living Cell Technologies (ASX:LCT) secures funding for third Parkinson trial

Living Cell Technologies (LCT) secures funding for its third clinical trial of NTCELL in Parkinson’s disease The aim of the third trial is to see if NTCELL can pause or delay the natural progression of Parkinson’s disease With this funding...

themarketherald.com.au LCT 3 years ago
Closing Bell: ASX starts the week with a 0.26pc gain and several M&A deals

The ASX saw a frenzy of M&A deals today and it sent the market higher. Companies completing deals included Ramelius Resources (ASX:RMS) buying Apollo Consolidated (ASX:AOP) and Class (ASX:CL1) being acquired by Hub24 (ASX:HUB) along wit...

Stockhead LCT 3 years ago
Closing Bell: ASX enters the weekend with second straight day of gains

It’s been a mixed week for the ASX but it has finished on a high. The ASX 200 closed 0.69% higher than yesterday, closing at 7,362 which marked a 3 week high but is still 3.5% above the all time high reached in mid-August. Travel stocks gai...

Stockhead LCT 3 years ago
Why are ASX healthcare shares Rhythm Biosciences and Zelira on the rise today?

Summary Diagnostics company Rhythm Biosciences has confirmed that LRF enhancements have shown to improve ColoSTAT® results. Cannabis medicines developer Zelira Therapeutics has entered into a partnership with Alternative Solutions for...

Kalkine Media LCT 3 years ago
Vale Em. Prof. Sir Robert Elliot

It is with sorrow that AusBiotech acknowledges the passing of Living Cell Technologies (LCT) Founder, Emeritus Professor Sir Robert Elliott.

BiotechDispatch LCT 4 years ago
ASX gold, New Zealand-headquartered small caps take a hit; investors told not to panic

The sudden drop in spot gold prices and reintroduction of COVID-19 restrictions in New Zealand have hit the relevant ASX small caps this morning. After 100 days of being virus-free, four COVID-19 cases were detected in the country. New Zeal...

Stockhead LCT 4 years ago
10 at 10: These ASX stocks are hanging high this morning

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead LCT 4 years ago
10 at 10: These ASX stocks have suited up this morning

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead LCT 4 years ago
Closing Bell: Today’s biggest small cap movers on the ASX

A quick wrap of the key winners and losers on Monday, July 6. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 712 stocks rose, 576 declined and 819 were u...

Stockhead LCT 4 years ago
Closing Bell: Today’s biggest small cap movers on the ASX

A quick wrap of the key winners and losers on Friday, July 3. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 736 stocks rose, 584 declined and 789 were u...

Stockhead LCT 4 years ago
Closing Bell: Today’s biggest small cap movers on the ASX

A quick wrap of the key winners and losers on Monday, June 22. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow potentially made market-moving announcements during the day. Today 556 stocks rose, 793 declined a...

Stockhead LCT 4 years ago
10 at 10: These ASX stocks are fluttering around this morning

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead LCT 4 years ago
10 at 10: These ASX stocks are on the charge this morning

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead LCT 4 years ago
Shareholder activism is on the rise at home and abroad; will it become the norm in share ownership?

Investment bank Lazard believes shareholder activism is going to become more rife in future. Shareholder activism occurs when existing shareholders publically attempt to influence a company’s behaviour. To meet the criteria they have to be...

Stockhead LCT 4 years ago
5 Small-cap Stocks under focus – SF1, LCT, KFE, MLM, DCL

Generally, stocks are bifurcated into four categories based on their market capitalization: Large cap, Mid cap, Small cap and Penny Stocks. Large and mid-cap stocks offer lower risks and lower returns, but on the other hand, if we look at t...

Kalkine Media LCT 5 years ago
These are the 22 small cap biotechs closest to bringing a drug to market

There are no shortage of small cap health and biotech companies listed on the ASX — around 140 or so — but less than 25 are anywhere close to their ultimate dream of bringing a drug successfully to market, a Stockhead analysis has found. Ta...

Stockhead LCT 5 years ago
10 at 10: These ASX stocks are pushing ahead this morning

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead LCT 5 years ago